Search

Now showing items 1-10 of 13

Efficient gene delivery to photoreceptors using AAV2/rh10 and rescue of the Rho?^'/?^' mouse

HUMPHRIES, PETER; FARRAR, JANE (Elsevier, 2015)

Prevention of autosomal dominant retinitis pigmentosa by systemic drug therapy targeting heat shock protein 90 (Hsp90)

FARRAR, JANE; KENNA, PAUL; KIANG, ANNA-SOPHIA; HUMPHRIES, MARIAN; HUMPHRIES, PETER; TAM, LAWRENCE; CAMPBELL, MATTHEW (2010)

Suppression and Replacement Gene Therapy for Autosomal Dominant Disease in a Murine Model of Dominant Retinitis Pigmentosa

MILLINGTON-WARD, SOPHIA; O'REILLY, MARY; PALFI, ARPAD; KILTY, CLAIRE; HUMPHRIES, MARIAN; KENNA, PAUL; FARRAR, JANE; HUMPHRIES, PETER; CHADDERTON, NAOMI (2011)

Panel-Based population next-generation sequencing for inherited retinal degenerations

HUMPHRIES, PETER; FARRAR, JANE (2016)

Influence of a quantitative trait locus on mouse chromosome 19 to the light-adapted electroretinogram.

FARRAR, JANE; HUMPHRIES, PETER (Association for Research in Vision and Ophthalmology, 2008)

Altered retinal microRNA expression profile in a mouse model of retinitis pigmentosa.

FARRAR, JANE; HUMPHRIES, PETER (BioMed Central, 2007)

Sensitivity of Photoreceptor-Derived Cell Line (661W) to Baculoviral p35, Z-VAD.FMK, and Fas-Associated Death Domain

FARRAR, JANE; HUMPHRIES, PETER; KENNA, PAUL (Association for Research in Vision and Ophthalmology, 2002)

Validation in mesenchymal progenitor cells of a mutation-independent ex vivo approach to gene therapy for osteogenesis imperfecta

FARRAR, JANE; HUMPHRIES, PETER (Oxford University Press, 2002)

On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention

FARRAR, JANE; HUMPHRIES, PETER (Nature Publishing Group, 2002)

Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10).

FARRAR, JANE; HUMPHRIES, MARIAN; HUMPHRIES, PETER; CAMPBELL, MATTHEW (2008)

Browse

All of TARA

This Academic/Research Unit

Discover

Author

Subject

Date Issued

Sponsor

Search

Efficient gene delivery to photoreceptors using AAV2/rh10 and rescue of the Rho?^'/?^' mouse

Prevention of autosomal dominant retinitis pigmentosa by systemic drug therapy targeting heat shock protein 90 (Hsp90)

Suppression and Replacement Gene Therapy for Autosomal Dominant Disease in a Murine Model of Dominant Retinitis Pigmentosa

Panel-Based population next-generation sequencing for inherited retinal degenerations

Influence of a quantitative trait locus on mouse chromosome 19 to the light-adapted electroretinogram.

Altered retinal microRNA expression profile in a mouse model of retinitis pigmentosa.

Sensitivity of Photoreceptor-Derived Cell Line (661W) to Baculoviral p35, Z-VAD.FMK, and Fas-Associated Death Domain

Validation in mesenchymal progenitor cells of a mutation-independent ex vivo approach to gene therapy for osteogenesis imperfecta

On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention

Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10).

Browse

All of TARA

This Academic/Research Unit

Discover

Author

Subject

Date Issued

Sponsor

Search

Advanced Search

Efficient gene delivery to photoreceptors using AAV2/rh10 and rescue of the Rho?^'/?^' mouse

Prevention of autosomal dominant retinitis pigmentosa by systemic drug therapy targeting heat shock protein 90 (Hsp90)

Suppression and Replacement Gene Therapy for Autosomal Dominant Disease in a Murine Model of Dominant Retinitis Pigmentosa

Panel-Based population next-generation sequencing for inherited retinal degenerations

Influence of a quantitative trait locus on mouse chromosome 19 to the light-adapted electroretinogram.

Altered retinal microRNA expression profile in a mouse model of retinitis pigmentosa.

Sensitivity of Photoreceptor-Derived Cell Line (661W) to Baculoviral p35, Z-VAD.FMK, and Fas-Associated Death Domain

Validation in mesenchymal progenitor cells of a mutation-independent ex vivo approach to gene therapy for osteogenesis imperfecta

On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention

Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10).